Lazabemide

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Lazabemide
Lazabemide.png
Systematic (IUPAC) name
N-(2-aminoethyl)-5-chloro-pyridine-2-carboxamide
Clinical data
  • (Prescription only)
Oral
Identifiers
103878-84-8
None
PubChem CID 71307
ChemSpider 64426
UNII 420HD787N9 YesY
KEGG D04681
Chemical data
Formula C8H10ClN3O
199.64 g/mol

Lazabemide (trade names Pakio, Tempium) is a reversible and selective inhibitor of monoamine oxidase B (MAO-B) that was under development as an antiparkinsonian agent.[1]

References[edit]

  1. ^ Henriot S, Kuhn C, Kettler R, Da Prada M. (1994). "Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings.". J Neural Transm Suppl. 41: 321–325. PMID 7931245.